share_log

Protagenic Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(5.4%),Steven Boyd(5.4%)

Protagenic Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(5.4%),Steven Boyd(5.4%)

美股SEC公告 ·  2022/02/14 18:19
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息